Clinical trial
CB-PRP in retinitis Pigmentosa and dry age-related macular degeneration (SiCord)
CB-PRP in retinitis Pigmentosa and dry age-related macular degeneration (SiCord)
| Trial Fact Box | |
|---|---|
| NCT Code | NCT04636853 |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Study type(s) | Interventional |
| Phase |
Phase 3
|
| Enrollment (Actual) | 20 |
| Study Start (Actual) | 23 December 2020 |
| Primary Completion (Actual) | 1 December 2021 |
| Study Completion (Actual) | 2 December 2021 |
Official Title:
Cord Blood Platelet-rich Plasma (CB-PRP) in Retinitis Pigmentosa and Dry Age-related Macular Degeneration
Brief Summary:
The study will provides the enrollment of patients with genetic retinal dystrophies with primary rod impairment and dry age-related macular degeneration (Geographic type) A subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP) will be performed only in one eye, the other eye will be considered as a control group.
A complete morpho-functional ophthalmological evaluation will be performed in all patients at each control.